From professional translators, enterprises, web pages and freely available translation repositories.
levertransaminasen
hepatic transaminases
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
levertransaminasen verhoogd
hepatic transaminases increased
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
stijging van levertransaminasen
hepatic transaminase elevations
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
verhoogde levertransaminasen in uw bloed
increased liver transaminases in your blood
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
verhogingen van levertransaminasen zijn gemeld.
elevations of liver transaminases have been reported.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
voorbijgaande, asymptomatische verhogingen van levertransaminasen
transient, asymptomatic elevations of hepatic transaminases (alt, ast), especially in early treatment (see section 4.4)
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
verhoging van levertransaminasen en alkalische fosfatase.
increase in liver transaminases and in alkaline phosphatase.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
stijging levertransaminasen, gewichtstoename, stijging totaal bilirubine
hepatic transaminases increased, weight increased, total bilirubin increased*
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
voorbijgaande en reversibele verhogingen van levertransaminasen zijn gemeld.
elevated serum lipid values usually return to normal on reduction of the dose or discontinuation of treatment and may also respond to dietary measures.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
levertransaminasen- stijging, gewichtstoename, stijging totaal bilirubine
hepatic transaminases increased, weight increased, total bilirubin increased*
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
in placebogecontroleerde studies werden stijgingen van levertransaminasen waargenomen.
in placebo-controlled studies, elevations of hepatic transaminases were observed.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
zeer vaak • verhoging van levertransaminasen (asat en alat) en alkalische fosfatase
rare
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
verhogingen van de levertransaminasen (alat/ asat; zie rubriek 4.4).
elevations of hepatic transaminases (alt/ ast; see section 4.4).
Last Update: 2012-04-11
Usage Frequency: 4
Quality:
de verhoogde waarden voor levertransaminasen leidden zelden tot de beëindiging van de behandeling met cresemba.
the elevations in liver transaminases rarely required discontinuation of cresemba.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
voorbijgaande, asymptomatische verhogingen van levertransaminasen (alat, asat), vooral in het begin van
transient, asymptomatic elevations of hepatic transaminases (alt, ast), especially in early treatment (see section 4.4)
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
in klinische onderzoeken zijn verhoogde waarden voor levertransaminasen waargenomen (zie rubriek 4.8).
elevated liver transaminases have been reported in clinical studies (see section 4.8).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
voorbijgaande, asymptomatische verhogingen van levertransaminasen (alat, asat), vooral in het begin van de behandeling
transient, asymptomatic elevations of hepatic transaminases (alt, ast), especially in early treatment (see section 4.4)
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
stopzetting wegens verhoogde levertransaminasen bedroeg <1% en was vergelijkbaar bij patiënten behandeld met tecfidera of placebo.
discontinuations due to elevated hepatic transaminases were <1% and similar in patients treated with tecfidera or placebo.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
voorbijgaande, asymptomatische verhogingen van levertransaminasen (alat, asat), vooral in het begin van de behandeling (zie
transient, asymptomatic elevations of hepatic transaminases (alt, ast), especially in early treatment (see section 4.4)
Last Update: 2012-04-11
Usage Frequency: 4
Quality:
ernstiger bijwerkingen zoals ernstige huiduitslag en stijgingen van levertransaminasen zijn ook gemeld (zie de paragraaf beschrijving van de geselecteerde bijwerkingen).
more serious adverse reactions such as serious skin rashes and hepatic transaminase elevations have also been reported (cf paragraph description of selected adverse reactions).
Last Update: 2017-04-26
Usage Frequency: 1
Quality: